KRAS and cancer: The abnormal activation of KRAS occurs in pancreatic ductal adenocarcinoma, nonsmall cell lung cancer NSCLC, colorectal cancer, and other tumors which can promote ROS generation and the metabolic reprogramming of cancer cells by regulating mitochondria function [78, 235].